“This trial will be conducted under the same FDA
Post# of 148177
Doesn’t this mean they can immediately inject patients in the severely ill protocol?
“CytoDyn expects to enroll patients in both the Mild-to-Moderately Ill and Severely Ill protocols very quickly under the same IND that was provided with a “safe to proceed” letter from the FDA.”